Healthy-Again, Your Path To Health and Recovery

Natural Non-Drug Cures - Therapies - Treatments - Remedies for Cancer, Heart Disease, AIDS, and other Chronic Illness


Let thy food be thy medicine, and thy medicine be thy food.
Hippocrates, Father of Medicine, 400 B.C.

Jonathan Campbell

Helping people take charge of their health

 


Introduction
Covid-19 Protection and Treatment
Covid-19 Supplement Protocol
Natural Therapies
How to Prevent/Stop Influenza
Natural Cancer Therapy
Natural Cardiovascular Disease Therapy
Natural Cholesterol Control Therapy
Natural Statin Injury Therapy
Type II Diabetes
What Is AIDS?
Natural AIDS Therapy
Natural Chronic Fatigue Therapy
Natural Hepatitis C Therapy
Natural Mental Disorders Therapy
Natural Sexual Dysfunction Therapy
Patient Empowerment
Menopause Naturally
Poverty In America
About Jonathan Campbell
Home Page

 

The 1994 EPA Dioxin Reassessment

Health Assessment, Volume III: Risk Characterization

REFERENCES FOR CHAPTER 9

Abbott, B.D.; Birnbaum, L.S. (1991). TCDD exposure of human embryonic palatal shelves in organ culture alters the differentiation of medial epithelial cells. Teratology 43: 119-132.

Ahlborg, U.G.; Becking, G.C.; Birnbaum, L.S.; Brouwer, A.; Derks, H.J.G.M.; Freeley, M.; Golor, G.; Hanberg, A.; Larsen, J.C.; Liem, A.K.D.; Safe, S.H.; Schlatter, C.; Waern, R.; Younes, M.; Yrjänheikki, E. (1994) Toxic equivalency factors for dioxin-like PCBs. Chemosphere 28(6): 1049-1067.

Air Force Health Study. (1991) An epidemiologic investigation of health effects in Air Force personnel following exposure to herbicides (Serum dioxin analysis of 1987 examination results).

Andersen, M.E.; Mills, J.J.; Gargas, M.L.; et al. (1993) Modeling receptor-mediated processes with dioxin: Implications for pharmacokinetics and risk assessment. Risk Anal. 13(1): 25-36.

Beck, H.; Eckart, K.; Mathar, W. (1989) Levels of PCDD's and PCDF's in adipose tissue of occupationally exposed workers. Chemosphere 18: 507-516.

Beck, H.; Dross, A.; Ende, M.; et al. (1991) Ergebnisse von Ruckstandsuntersuchungen auf polychlorierte Dibenzofurane und Dibenzodioxine in Frauenmilch aus der Bundesrepublik Deutschland [Results of the analysis for residue of polychlorinated dibenzodioxins and dibenzofurans in human milk from the Federal Republic of Germany]. Bundesgesundheitsblatt 34: 564-568.

Beck, H.; Dross, A.; Mathar, W. (1994) PCDD and PCDF exposure and levels in humans in Germany. Environ. Health Perspect. 102(Suppl 1): 173-185.

Bertazzi, P.A.; Pesatori, A.C.; Consinni, D.; Tironi, A.; Landi, M.T.; Zochetti, C. (1993) Cancer incidence in a population accidently exposed to 2,3,7,8-tetrachlorodibenzo-papa-dioxin. Epidemiology 4(5): 398-406.

Burelson, G.R.; Lebrec, H.; Yang, Y.; Ibanes, J.D.; Penningoton, K.N.; Birnbaum, L.S. (1994) Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza host resistance in mice. Fund. Appl. Toxicol; in press.

Carrier, G. (1991) Response de l’organiisme humain aux BPC, dioxines et furanneset analyse de risques toxiques. Passeur Press, Canada.

Carrier, G.; Brunet, R.; Brodeur, J. (Submitted) Physiologically-based modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. I. Nonlinear distribution of PCDD/PCDF body burden between liver and adipose tissue.

Chen, Y.-C.J.; Guo, Y.-L.; Hsu, C.-C.; Rogan, W.J. (1992) Cognitive development of Yu-Chen (`Oil Disease') children prenatally exposed to heat-degraded PCBs. J. Am. Med. Assoc. 268: 3213-3218.

Clark, G.; Tritscher, A.; Bell, D.; Lucier, G.W. (1992) Integrated approach for evaluating species and interindividual differences in responsiveness to dioxins and structural analogs. Environ. Health Perspect. 98: 125-132.

Cohen, G.M.; Bracken, W.P.; Iyer, R.P.; et al. (1979) Anticarcinogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene tumor initiation and its relationship to DNA binding. Cancer Res. 39: 4027-4033.

Columbia River Intertribal Fish Commission (1993) A fish consumption survey of the Umtilla, Nez Perce, Yakima, and Warm Springs tribes of the Columbia River Basin. Peer Review Draft Report.

Cook, J.C.; Dold, K.M.; Greenlee, W.F. (1987) An in vitro model for studying the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin to human thymus. Toxicol. Appl. Pharmacol. 89: 256-268.

Couture, L.A.; Abbott, B.D.; Birnbaum, L.S. (1990) A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: recent advances toward understanding the mechanism. Teratology 42: 619-632.

DeVito, M.J.; Birnbaum, L.S. (1994) Toxicology of dioxin and related compounds. Toxicology; in press.

DeVito, M.J.; Maier, W.E.; Diliberto, J.J.; Birnbaum, L.S. (1993) Comparative ability of various PCBs, PCDFs, and TCDD to induce cytochrome P450 1A1 and 1A2 activity following 4 weeks of treatment. Fund. Appl. Toxicol. 20: 125-130.

DeVito, M.J.; Ma, X.; Babish, J.G.; Menache, M.; Birnbaum, L.S. (1994) Dose-response relationships in mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor and protein tyrosine phosphorylation. 124: 82-90.

Dewailly, E.; Ryan, J.J.; Laliberte, C.; et al. (1994) Exposure of remote maritime populations to coplanar PCBs. Environ. Health Perspect. 102 (Suppl 1): 205-209.

DiGiovanni, J.; Berry, D.L.; Gleason, G.L.; et al. (1980) Time-dependent inhibition by 2,3,7,8-tetrachlorodibenzo-p-dioxin of skin tumorigenesis with polycyclic hydrocarbons. Cancer Res. 40: 1580-1587.

Diliberto, J.J.; Akube, P.I.; Luebke, R.W.; Birnbaum, L.S. (Submitted) Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.

Egeland, G.M.; Sweeney, M.H.; Fingerhut, M.A.; Halperin, W.E.; Wille, K.K.; Schnoor, T.M. (1994) Serum 2,3,7,8-tetrachlorodibenzo-p-dioxin's (TCDD) effect on total serum testosterone and gonadotropins in occupationally exposed men. Amer. J. Epidemiol. 139: 272-281.

Enan, E.; Liu, P.C.; Matsumura, F. (1992) 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) causes reduction of glucose transporting activities in the plasma membranes of adipose tissue and pancreas from the guinea pig. J Biol. Chem. 267: 19785-19791.

Fingerhut, M.A.; Halperin, W.E.; Marlow, B.S.; Piacetelli, L.A.; Honchar, P.A.; Sweeney, M.H.; Greife, A.L.; Dill, P.A.; Steenland, K.; Suruda, A.J. (1991) Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N. Engl. J. Med. 342: 212-218.

Furst, P.; Furst, C.; Groebel, W. (1990) Levels of PCDDs and PCDFs in food stuffs from the Federal Republic of Germany. Chemosphere 20(7-9): 787-792.

Furst, P.; Furst, L.; Widmers, K. (1991) Body burden with PCDD and PCDF from food. In: Gallo, M.; Scheuplein, R.; Van der Heijden, K., eds. Biological basis for risk assessment of dioxin and related compounds. Banbury report No. 35. Plainview, NY: Cold Springs Harbor Laboratory Press.

Ganong W.F. (1982) Review of medical physiology, 11th ed. Los Altos, CA: Lange Medical Publications.

Gilman, A.; Newhook, R. (1991) An updated assessment of the exposure of Canadians to dioxins and furans. Chemosphere 23: 1661-1667.

Greenlee, W.F.; Dold, K.M.; Irons, R.D.; Osborne, R. (1985) Evidence for direct action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thymic epithelium. Toxicol. Appl. Pharmacol. 79: 112-120.

Guo, Y.L.; Lin, C.J.; Yao, W.J.; Ryan, J.J.; Hsu, C.C. (1994) Musculoskeletal changes in children prenatally exposed to polychlorinated biphenyls and related compounds (Yu-Cheng children). J. Toxicol. Environ. Health 41: 83-93.

Harrad, S.J.; Jones, K.C. (1992) A source inventory and budget for chlorinated dioxins and furans in the United Kingdom environment. Science of the Total Environment 126: 89-107.

Hites, R.A. (1991) Atmospheric transport and deposition of polychlorinated dibenzo-p-dioxins and dibenzofurans. Prepared for the U.S. Environmental Protection Agency, Methods Research Branch, Atmospheric Research and Assessment Laboratory, Office of Research and Development, Research Triangle Park, NC. EPA/600/3-91/002.

Hong, R.; Taylor, K.; Abounor, R. (1989) Immune abnormalities associated with chronic TCDD exposure in rhesus monkeys. Chemosphere 18: 313-320.

Hsu, C.C.; Hu, H.F.; Lai, R.J.; Ko, H.C.; Chem, Y.C. (1993) Behavioral development of Yucheng children as compared to their matched controls. Dioxin '93 14: 239-242.

Johnson, R.D.; Tietge, J.E.; Botts, S. (1992) Carcinogenicity of 2,3,7,8-TCDD to Medaka. The Toxicologist 12(1): 138.

Kahn, P.C.; Gochfeld, M.; Nygren, M.; et al. (1988) Dioxins and dibenzofurans in blood and adipose tissue of Agent Orange-exposed Vietnam veterens and matched controls. J. Am. Med. Assoc. 259: 1661-1667.

Kedderis, L.B.; Mills, J.J.; Andersen, M.E.; Birnbaum, L.S. (1993) A physiologically based pharmacokinetic model for 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in the rat: Tissue distribution and CYP1A2 induction. Toxicol. Appl. Pharmacol. 121: 87-98.

Kociba, R.J.; Keyes, D.G.; Beyer, J.E.; Carreon, R.M.; Wade, C.E.; Dittenber, D.A.; Kalnins, R.P.; Frauson, L.E.; Park, C.N.; Barnard, S.D.; Hummel, R.A.; Humiston, C.G. (1978) Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 46: 279-303.

Kogevinas, M.; Saracci, R.; Winkelman, R.; et al. (1993) Cancer incidence and mortality in women occupationally exposed to chlorophenoxy herbicides, chlorophenols and dioxins. Cancer Causes and Control, 4: 457.

Kohn, M.C.; Portier, C.J. (1993) Effects of the mechanism of receptor-mediated gene expression on the shape of the dose-response curve. Risk Analysis 13(5): 565-572.

Kohn, M.C.; Lucier, G.W.; Clark, G.C.; et al. (1993) A mechanistic model of effects of dioxin on gene expression in the rat liver. Toxicol. Appl. Pharmacol. 120: 138-154.

Lai, T.J.; Chen, Y.C.; Chou, W.J.; Guo, Y.L.; Ko, H.C.; Hsu, C.C. (1993) Cognitive development in Yucheng children. Dioxin '93 14: 247-250.

Leung, H.-W.; Paustenbach, D.J.; Murray, F.J.; Andersen, M.E. (1990a) A physiologically based pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Toxicol. Appl. Pharmacol. 103: 399-410.

Leung, H.-W.; Poland, A.P.; Paustenbach, D.J.; Andersen, M.E. (1990b) Dose dependent pharmacokinetics of [125I]-2-iodo-3,7,8-trichlorodibenzo-p-dioxin in mice: Analysis with a physiological modeling approach. Toxicol. Appl. Pharmacol. 103: 411-419.

Lucier, G.W. (1991) Humans are a sensitive species to some of the biochemical effects of structural analogs of dioxin. Environment. Toxicol. Chem. 10: 727-735.

Lucier, G.W.; Tritscher, A.; Goldsworthy, T.; et al. (1991) Ovarian hormones enhance 2,3,7,8-TCDD mediated increases in cell proliferation and preneoplastic foci in a two-step model for rat hepatocarcinogenesis. Cancer Res. 51: 1391-1397.

Mably, T.A.; Moore, R.W.; Peterson, R.E. (1992a) In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. I. Effects on androgenic status. Toxicol. Appl. Pharmacol. 114: 97-107.

Mably, T.A.; Bjerke, D.L.; Moore, R.W.; Gendron-Fitzpatrick, A.; Peterson, R.E. (1992b) In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. III. Effects on spermatogenesis and reproductive capability. Toxicol. Appl. Pharmacol. 114: 108.

Manz, A.; Berger, J.; Dwyer, J.H.; et al. (1991) Cancer mortality among workers in a chemical plant contaminated with dioxin. Lancet 338: 959-964.

Maronpot, R.R.; Foley, J.F.; Takahashi, K.; Goldsworthy, T.; Clark, G.; Tritscher, A.; Portier, C.; Lucier, G. (1993) Dose response for TCDD promotion of hepatocarinogenesis in rats initiated with DEN: Histologic, biochemical and cell proliferation endpoints. Environ. Health Perspect. 101: 634-642.

McNulty, W.P. (1985) Toxicity and fetotoxicity of TCDD, TCDF, and PCB isomers in rhesus macaques (Macaca mulatta). Environ. Health Perspect. 60: 77.

MMWR (Morbidity and Mortality Weekly Report). (1988) Serum 2,3,7,8-tetrachloro-dibenzo-p-dioxin levels in Air Force health study participants—preliminary report. Centers for Disease Control, Atlanta, GA. 3(20): 309-311.

Moore, R.W.; Potter, C.L.; Theobald, H.M.; Robinson, J.A.; Peterson, R.E. (1985) Androgenic deficiency in male rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 79: 99-111.

National Toxicology Program (NTP). (1980) Bioassay of a mixture of 1,2,3,6,7,8-hexachlorodibenzo-p-dioxin and 1,2,3,7,8,9-hexachlorodibenzo-p-dioxin for possible carcinogenicity (gavage study). NTP Tech. Rept. Ser. no. 198. Research Triangle Park, NC: U.S. DHHS, PHS.

National Toxicology Program (NTP). (1982) Bioassay of 2,3,7,8-tetrachlorodibenzo-p-dioxin for possible carcinogenicity (gavage study). Technical report series No. 102, National Toxicology Program, Research Triangle Park, NC.

National Toxicology Program (NTP). (1982) Carcinogenicity bioassay of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Osborne-Mendel rats and B6C3F1 mice (gavage study). NTP Tech. Rept. Ser. no. 209. Research Triangle Park, NC: U.S. DHHS, PHS.

Neubert, R.; Jacob-Muller, U.; Helge, H.; Stahlmann, R.; Neubert, D. (1991) Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system 2. In vitro effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on lymphocytes of venous blood from man and a non-human primate (Callithrix jacchus). Arch. Toxicol. 65: 213-219.

Neubert, R.; Golor, G.; Stahlmann, R.; Helge, H.; Neubert, D. (1992) Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system. 4. Effects of multiple dose treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on peripheral lymphocyte subpopulations of a non-human primate (Callithrix jacchus). Arch. Toxicol. 66: 250.

Patterson, D.G., Jr.; Needham, L.L.; Pirkle, J.L.; et al. (1988) Correlation between serum and adipose tissue levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin in 50 persons from Missouri. Arch. Environ. Contam. Toxicol. 17: 139-143.

Patterson, D.G., Jr.; Todd, G.D.; Turner, W.E.; et al. (1994) Levels of non-ortho-substituted polychlorinated biphenyls, dibenzo-p-dioxins, and dibenzofurans in human serum and adipose tissue. Environ. Health Perspect. 102 (Suppl 1): 195-204.

Pirkle, J.L.; Wolfe, W.H.; Patterson, D.G., Jr.; et al. (1989) Estimates of the half-life of 2,3,7,8-TCDD in Vietnam veterans of Operation Ranch Hand. J. Toxicol. Environ. Health 27: 165-171.

Poiger, H.; Schlatter, C. (1986) Pharmacokinetics of 2,3,7,8-TCDD in man. Chemosphere 15(9-12): 1489-1494.

Poland, A.; Palen, D.; Glover, E. (1982) Tumor promotion by TCDD in skin of HRS/J hairless mice. Nature 300: 271.

Portier, C.; Tritscher, A.; Kohn, M.; Sewall, C.; Clark, G.; Edler, L.; Hoel, D.; Lucier, G. (1993) Ligand/receptor binding for 2,3,7,8-TCDD: Implications for risk assessment. Fund. Appl. Toxicol. 20: 48-56.

Probst, M.R.; Reisz-Porszasz, S.; Agbunag, R.V.; Ong, M.S.; Hankinson, O. (1993) Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action. Mol. Pharmacol. 44: 511-518.

Puvel, S.M.; Sakamoto, M. (1988) Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on murine skin. J. Invest. Dermatol. 90: 354-358.

Rao, M.S.; Subbaro, V.; Prasad, J.D.; Scarpelli, D.C. (1988) Carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the Syrian hamster. Carcinogenesis 9(9): 1677-1679.

Rappe, C. (1991) Sources of human exposure to PCDDs and PCDFs. In: Gallo, M.; Scheuplein, R.; Van der Heijam, K., eds. Biological basis for risk assessment of dioxin and related compounds. Banbury report No. 35. Plainview, NY: Cold Springs Harbor Laboratory Press.

Reier, S.E.; Martin, D.C.; Bowman, R.E.; Dmowski, W.P.; Becker, J.L. (1993) Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fund. Appl. Toxicol. 21: 433-441.

Rogan, W.J.; Gladen, B.C.; Hung, K.-L.; Koong, S.-L.; Shih, L.-Y.; Taylor, J.S.; Wu, Y.-C.; Yang, D.; Ragan, N.B.; Hsu, C.-C. (1988). Congenital poisoning by polychlorinated biphenyls and their contaminants in Taiwan. Science 241: 334-336.

Rose, J.Q.; Ramsey, J.C.; Wentzler, T.H.; Hummel, R.A.; Gehring, P.J. (1976) The fate of 2,3,7,8-tetrachlorodibenzo-p-dioxin following single and repeated oral doses to the rat. Toxicol. Appl. Pharmacol. 36: 209.

Roth, W.L.; Weber, L.W.D.; Stahl, B.U.; Rozman, K. (1993) A pharmacodynamic model of triglyceride transport and deposition during feed deprivation or following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the rat. Toxicol. Appl. Pharmacol. 120: 126-137.

Ryan, J.J.; Gasiewicz, T.A.; Brown, J.R., Jr. (1990). Human body burden of polychlorinated dibenzofurans associated with toxicity based on the Yusho and Yucheng incidents. Fund. Appl. Toxicol. 15: 722.

Safe, S. (1990) Polychlorinated biphenyls, dibenzo-p-dioxins, and dibenzofurans and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors. CRC Crit. Rev. Toxicol. 21: 51-88.

Saracci, R.; Kogevinas, M.; Beratzzi, P.; et al. (1991) Cancer mortality in workers exposed to chlorophenoxy herbicides and chlorophenols. Lancet 38(3774): 1027-1032.

Sauer, R.M. (1990) 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Sprague-Dawley rats. Submitted to the Maine Science Advisory Panel by Pathco, Inc., Ijamsville, MD, March 13, 1990.

Schantz, S.L.; Bowman, R.E. (1989). Learning in monkeys exposed perinatally to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Neurotoxicol. Teratol. 11: 13.

Schecter, A. (1991) Dioxins and related compounds in humans and the environment. In: Gallo, M.; Scheuplein, R.; Van der Heijden, K., eds. Biological basis for risk assessment of dioxin and related compounds. Banbury report No. 35. Planview, NY: Cold Springs Harbor Laboratory Press.

Schecter, A.; Papke, O.; Ball, M.; Startin, J.R.; Wright, C.; Kelly, M. (1992) Dioxin and dibenzofuran levels in food from the United States as compared to levels in food from other industrialized countries. 12th International Symposium on Dioxins and Related Compounds; Tampere, Finland; August 1992. Finnish Institute of Occupational Health, Helsinki, Finland, pp. 243-246.

Schwetz, B.A.; Norris, J.M.; Sparschu, G.L.; Rowe, U.K.; Gehring, P.J.; Emerson, J.L.; Gerbig, C.G. (1973) Toxicology of chlorinated dibenzo-p-dioxins. Environ. Health Perspect. 5: 87.

Sewall, C.H.; Lucier, G.W.; Tritscher, A.M.; Clark, G.C. (1993) TCDD-mediated changes in hepatic epidermal growth factor receptor may be a critical event in the hepatocarcinogenic action of TCDD. Carcinogenesis 14: 1885-1893.

Sielken, R.L., Jr. (1987) Statistical evaluations reflecting the skewness in the distribution of TCDD levels in human adipose tissue. Chemosphere 16(8/9): 2135-2140.

Spink, D.C.; Lincoln, D.C.; Dickerman, H.W.; Gierthy, J.F. (1990) 2,3,7,8-Tetra-chlorodibenzo-p-dioxin causes an extensive alteration in 17b -estradiol metabolism in MCF-7 breast tumor cells. Proc. Natl. Acad. Sci. USA. 87: 6917-6921.

Squire, R.A. (1980) Pathologic evaluations of selected tissues from the Dow Chemical TCDD and 2,4,5-T rat studies. Submitted to Carcinogen Assessment Group, U.S. Environmental Protection Agency on August 15 under contract no. 68-01-5092.

Sutter, T.R.; Guzman, K.; Dold, K.M.; Greenlee, W.F. (1991) Targets for dioxin: Genes for plasminogen activator inhibitor-2 and interleukin-1B. Science 254: 415-418.

Svensson, B.G.; Neisson, A.; Hansson, M.; et al. (1991) Exposure to dioxins and dibenzofurans through consumption of fish. N. Engl. J. Med. 324(1): 8-12.

Sweeney, M.H.; Hornung, R.W.; Wall, D.K.; Fingerhut, M.A.; Halperin, W.E. (1992) Prevalence of diabetes and elevated serum glucose levels in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Presented at 12th International Symposium on Dioxins and Related Compounds: August 24-28, Tampere, Finland.

Theelen, R.M.C. (1991) Modeling of human exposure to TCDD and I-TEQ in the Netherlands: background and occupational. In: Gallo, M.; Scheuplein, R.; Van der Heijden, K., eds. Biological basis for risk assessment of dioxin and related compounds. Banbury report No. 35. Plainview, NY: Cold Springs Harbor Laboratory Press.

Tritscher, A.M.; Goldstein, J.A.; Portier, C.J.; McCoy, Z.; Clark, G.C.; and Lucier, G.W. (1992) Dose response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: Quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver. Cancer Res. 52: 3436-3442.

U.S. Environmental Protection Agency. (1989) Interim procedures for estimating risks associated with exposures to mixtures of chlorinated dibenzo-p-dioxins and dibenzofurans (CDDs and CDFs) and 1989 update. Risk Assessment Forum, EPA/625/3-89/016. National Technical Information Service, Springfield, VA; PB90-145756.

U.S. Environmental Protection Agency. (1991) Chlorinated dioxins and furans in the general U.S. population: NHATS FY87 results. Washington, D.C.: Office of Toxic Substances. EPA-560/5-91-003.

U.S. Environmental Protection Agency. (1994) Estimating exposure to dioxin-like compounds. Prepared by the Office of Health and Environmental Assessment, Office of Research and Development, Washington, DC. External Review Draft, 3 vol. EPA/600/6-88/005Ca, Cb, Cc.

U.S. Environmental Protection Agency Science Advisory Board. (1989) Review of draft documents: A cancer risk specific dose estimate for 2,3,7,8-TCDD and estimating exposures to 2,3,7,8-TCDD. Washington, D.C.: EPA Science Advisory Board Ad Hoc Dioxin Panel.

Van den Heuvel, J.P.; Clark, G.C.; Kohn, M.C.; Tritscher, A.M.; Greenlee, W.F., Lucier, G.W.; Bell, D.A. (1994) Dioxin-responsive genes: Examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Cancer Res. 54: 62-68.

Wendling, J.M.; Orth, R.G. (1990) Determination of [3H]-2,3,7,8-tetrachlorodibenzo-p-dioxin in human feces to ascertain its relative metabolism in man. Anal. Chem. 62: 796-800.

White, T.E.K.; Gasiewicz, T.A. (1993) The human estrogen receptor structural gene contains a DNA sequence that binds activated mouse and human Ah receptors: A possible mechanism of estrogen receptor regulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Biophys. Res. Comm. 193: 956-962.

Whitlock, J. P., Jr. (1990) Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Ann. Rev. Pharmacol. Toxicol. 30: 251-277.

Wolfe, W.; Michalek, J.; Miner, J. Needham, L.; Patterson, D.; Jr. (1992) Diabetes versus dioxin body burden in veterans of Operation Ranch Hand. Presented at 12th International Symposium on Dioxins and Related Compounds; August 24-28; Tampere, Finland.

Wolfe, W.H.; Michalek, J.E.; Miner, J.C.; et al. (1994) Determinants of TCDD half-life in veterans of Operation Ranch Hand. J. Toxicol. Environ. Health 41: 481-488.

Wood, S.C.; Jeong, H.G.; Morris, D.L.; Holsapple, M.P. (1993) Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human tonsilar lymphocytes. Toxicology 81:131-143.

World Health Organization (WHO). (1988) PCBs, PCDDs, and PCDFs in breast milk: Assessment of health risks. Environ. Health 29.

Zinkl, J.G.; Vos, J.G.; Moore, J.A.; Gupta, B.N. (1973) Hematologic and clinical chemistry effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals. Environ. Health Perspect. 5: 111-118.

Zober, A.; Messerer, P.; Huber, P. (1990) Thirty-four year follow-up of BASF employees exposed to 2,3,7,8-TCDD after the 1953 accident. Int. Arch. Occup. Environ. Health 62: 138-157.

Continue to Tables



Payment/Donation Request

If you find that the information on this site has provided you  with useful health information, or you would like to contribute to help the cause of providing this kind of service to people, please consider a modest payment for these information services.

I use my Healthy-Again PayPal account for the payment button, and you can use your PayPal account or any credit or debit card for payment. I have programmed the button to be a payment for information services, so you will not be charged any extra transaction fees. Select the amount you would like to pay. Any amount will be gratefully received.

If you don't have a PayPal account, PayPal will allow you to use any credit or debit card. PayPal is a completely safe, data secure funds transfer and payment service. Look for the lock symbol next to the PayPal URL (https://www.paypal.com), which guarantees that your payment is secure and encrypted.

Payment Options

Natural Therapy Home Page

Download A Natural Therapy Guide

©Graphics, Web design, and content Copyright 2003-2021 by Jonathan L. Campbell.
HealthyAgain and HealthyHomes are trademarks of Jonathan L. Campbell of Massachusetts, as of June 1, 2010
 

Healthy-Again, Your Path To Health and Recovery
124 Metropolitan Ave.
Roslindale, MA 02131-4208

https://www.healthy-again.net


Could Vitamin C stop the Ebola epidemic?

Diabetes, Pre-diabetes, and Severe Hypoglycemia are 100% corellated to Cardiovascular Disease

All health guides are now free for download

Now Available For Free Download: The Looting of Social Security by economist Alan Smith, http://www.thebiglie.net

Japan Nuclear Emergency and Worldwide Fallout - What To Do? http://www.healthy-again.net/japannuclearemergency.htm

Has your doctor prescribed Lipitor or another statin drug? Just say no! http://www.healthy-again.net/lipitor.htm

You don't need to take statin drugs...please don't take them! http://www.healthy-again.net/lipitor.htm

Muscle aches, weakness, numbness, brain fog - have you been harmed by Lipitor? http://www.healthy-again.net/lipitor.htm

Can 40 million people be wrong on Lipitor? Yes they can! http://www.healthy-again.net/wrongonlipitor.htm

Lipitor may ruin your health! http://www.healthy-again.net/lipitor.htm

Read about Lipitor side effects - http://www.healthy-again.net/lipitor.htm

If you are seeking a natural therapy, treatment, remedy, or cure for cancer, heart disease, AIDS, or other chronic illness: go to http://www.healthy-again.net

Swine Flu Vaccine Causes Miscarriage: http://www.healthy-again.net/swinefluvaccine.htm

Effective Natural Treatment for cancer: http://www.healthy-again.net/cancertherapy.htm

Cure - Reverse - Heart Disease: http://www.healthy-again.net

Effective Natural Treatment for heart disease: http://www.healthy-again.net/cvd.htm

Effective Natural Treatment for hepatitis: http://www.healthy-again.net/hepatitis.htm

30-60 Million People Are Being Harmed By Statin Drugs. Are You One Of Them? http://www.healthy-again.net/lipitor.htm

Miracle Mineral Supplement (MMS) Is A Toxic Fraud - Please Don't Take It! http://www.healthy-again.net/mms.htm

Colloidal Silver is Toxic - Don't Take It! http://www.healthy-again.net/silver.htm

Alternative "treatments" and "cures" to avoid:
Protocel (also called Cancell, Cantron, Sheridan's Formula)
Poly-MVA
Infrared sauna (especially far infrared, which actually causes cancer)
Cesium therapy
Miracle Mineral Supplement (MMS)
Zeolite liquid (NCD)
Essiac Tea
Alkaline pH
Coral Calcium
Colloidal Silver
Any treatment that specifies not to take Vitamin C
Fasting
"Fruit-only" regimens

http://www.healthy-again.net/therapiestoavoid.htm

Thinking about getting an HIV Test? Don't! http://www.healthy-again.net/aidtests.htm

Sudden Infant Death Syndrome (SIDS) Can Be Avoided! http://www.healthy-again.net/sids.htm

What's Wrong With Dricore: http://www.healthy-again.net/homeqa/dricore.htm

Reliable Concrete Cutting Massachusetts: http://www.healthy-again.net/homeqa/bcd.htm

Looting Social Security - How Reagan and Greenspan Stole the Trust Fund: http://www.thebiglie.net

How to Buy Siliver and Gold - An Economic and Health Survival Guide - Navigating Through Economic Turmoil: http://www.healthy-again.net/community-alert/survivalguides.htm

Bauman Remodeling of Dedham, a review: http://www.healthy-again.net/homeqa/contractorfrom.htm

Stop Spam - Subscribe to SpamCop - http://www.spamcop.net

Reduce The Burden of the HIV and AIDS diagnosis - http://www.reducetheburden.org

Quitting AIDS drugs is hard to do - http://www.healthy-again.net/quittingaidsdrugs.htm

Danger - Never Get An HIV Test - Ever! http://www.healthy-again.net/aidstests.htm

What Is AIDS? http://www.healthy-again.net/aids.htm

Conventional Medicine Does Not Provide Answers - http://www.healthy-again.net/conventionalmedicine.htm

Healthy-Again Computers - Buying And Maintaining Computer Equipment

Why My HP Printer Stopped Working - HP's Business Model

How To Avoid The HP "Firmware Update"

HP Printer Firmware Downgrade Links